SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Korablina Elena A (Last) (First) (Middle) 383 MADISON AVENUE (Street) NEW YORK NY 10179-0001 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol JPMORGAN CHASE & CO [ JPM ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Corporate Controller
	3. Date of Earliest Transaction (Month/Day/Year) 01/13/2023
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/13/2023		M		2,940	A	$0(1)	22,658	D
Common Stock	01/13/2023		M		2,746	A	$0(1)	25,404	D
Common Stock	01/13/2023		M		1,630	A	$0(1)	27,034	D
Common Stock	01/13/2023		M		1,262	A	$0(1)	28,296	D
Common Stock	01/13/2023		F		4,382	D	$139.145	23,914	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	01/13/2023		M			1,630	(2)	01/13/2023	Common Stock	1,630	$0.0000	0.0000	D
Restricted Stock Units	(1)	01/13/2023		M			2,746	(3)	01/13/2024	Common Stock	2,746	$0.0000	2,747	D
Restricted Stock Units	(1)	01/13/2023		M			1,262	(4)	01/13/2025	Common Stock	1,262	$0.0000	3,864	D
Restricted Stock Units	(1)	01/13/2023		M			2,940	(5)	01/13/2026	Common Stock	2,940	$0.0000	8,822	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of JPMC common stock.

2. Restricted stock units vest 1/3 on each of the following dates: January 13, 2021, January 13, 2022, and January 13, 2023. As Identified Staff at the time of grant, shares resulting from vesting must be held for 12 months from vesting date.

3. Restricted stock units grant of 3,417 shares will vest as follows: 1,139 shares on January 13, 2022, 1,139 shares on January 13, 2023, and 1,139 shares on January 13, 2024. The shares resulting from vesting are subject to a hold for 6 months from vesting date. Restricted stock units grant of 4,822 shares will vest as follows: 1,607 shares on January 13, 2022, 1,607 shares on January 13, 2023, and 1,608 shares on January 13, 2024. The shares resulting from vesting are subject to a hold for 12 months from vesting date.

4. Restricted stock units grant of 6,310 shares vest as follows: 1,262 shares on January 13, 2021, 1,262 shares on January 13, 2022, 1,262 shares on January 13, 2023, 1,262 shares on January 13, 2024, and 1,262 shares on January 13, 2025. As Identified Staff at the time of grant, shares resulting from vesting must be held for 12 months from vesting date. Restricted stock units grant of 1,340 shares vest as follows: 670 shares on January 13, 2024, and 670 shares on January 13, 2025.

5. Restricted stock units grant of 5,600 shares vests as follows: 1,400 shares on January 13, 2023, 1,400 shares on January 13, 2024, 1,400 shares on January 13, 2025, and 1,400 shares on January 13, 2026. As Identified Staff at the time of grant, the shares resulting from vesting must be held for 12 months from vesting date. Restricted stock units grant of 7,702 shares vests as follows: 1,540 shares on January 13, 2022, 1,540 shares on January 13, 2023, 1,540 shares on January 13, 2024, 1,541 shares on January 13, 2025, and 1,541 shares on January 13, 2026. As Identified Staff for a portion of year to which the grant relates, the shares resulting from vesting must be held for 12 months from vesting date.

	/s/ Holly Youngwood under POA	01/17/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.